Medicenna Therapeutics medicenna.com


Public list: BIO 2016 (619) Pharma Startups (4733) Cancer Therapeutics (1136)

Medicenna Therapeautics is a clinical stage, privately held, immuno-oncology company developing Interleukin-4 Empowered Cytokines (IL4-ECs) that specifically target the Interleukin-4 Receptor (IL4R). The IL4R is over-expressed by 20 different cancers, cancer stem cells and immunosuppressive cells of the tumor micro-environment (TME). Medicenna's IL4-ECs have the potential to not only purge the tumor but also un-blind the immune system to cancer thereby altering the treatment paradigm for a large...Show all

Medicenna Therapeautics is a clinical stage, privately held, immuno-oncology company developing Interleukin-4 Empowered Cytokines (IL4-ECs) that specifically target the Interleukin-4 Receptor (IL4R). The IL4R is over-expressed by 20 different cancers...Show all

Company (Acquired)

Phone: 604-671-6673

Fax:

1920 Yonge St

Toronto, M4S 3E6
Ontario, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Medicenna Therapeutics $21.6M Feb 6, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Medicenna Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Interleukin-4 receptor-binding fusion proteins and uses thereof Sep 24, 2014 Application